Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEOPLE - Calypte Biomedical (US) makes appointment:

This article was originally published in Clinica

Executive Summary

Calypte Biomedical (Alameda, California), a developer and marketer of urine-based diagnostic products and services, has appointed scientists Richard George and Ronald Mink to lead the company's development of rapid assays for the detection of HIV antibodies. Dr George most recently served as senior vice-president at OraSure Technologies and is a 30-year veteran of the Centers for Disease Control and Prevention. Dr Mink, who most recently served as director of R&D at OraSure, is the inventor of the first OraQuick HIV-1 rapid prototypes.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062766

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel